Atherotech Inc has announced the promotion of executives Mike Mullen, Bob Shufflebarger and Scott Rezek at its Birmingham headquarters.
Chief Financial Officer Mullen will lead Atherotech as President, Shufflebarger, who was the Vice President of Operations, now assumes
expanded duties as Chief Operating Officer and Scott Rezek, who was leading marketing, will assume expanded duties as Vice President of Commercial Operations.
"These three individuals have balanced skill sets involving business as well as technology expertise," Atherotech Board Member Dr Lawrence Greer of Birmingham said. "They are local, invested and passionate about the viability of the company’s products."
Mullen is an experienced accounting and finance executive who also brings perspective gained from a unique background combining accounting and laboratory sciences. As CFO, Mullen worked to promote Atherotech’s VAPR (Vertical Auto Profile) Cholesterol Test to physicians and expand business-to-business diagnostic lab sales. He led and was involved in several rounds of financing from institutional investors. Mullen previously served as the controller at Atherotech, where he managed the accounting, reimbursement and accounts payable departments.
An integral part of Atherotech since 2000, Shufflebarger has worked with early stage technology companies for most of his career. Prior to Atherotech he managed marketing and business development activities for Southern Research Institute, a contract research organization in Birmingham.
Rezek’s new duties will include sales, customer service and business development in addition to marketing the VAP Cholesterol Test and
Also announced are plans to add an expanded panel of cardiovascular tests to complement Atherotech’s advanced lipid profile, the VAP Test. "The key is to adapt to strategic developments within the industry and to implement programs to extract value from the changes therein," Greer explained. "This will be done by maximizing the value of the core VAP technology with additional product offerings."